Li Lin
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Oncology top 2%
- Cytokine Signaling Pathways and Interactions
- Cancer Cells and Metastasis
- COVID-19 and healthcare impacts
Papers in
- Oncology 27
- Cytokine Signaling Pathways and Interactions 19
- Cancer Cells and Metastasis 4
-
- COVID-19 Clinical Research Studies 9
- Co-authors
- Jiayuh Lin (23 shared papers)Jiagao Lv (19 shared papers)Chenglong Li (20 shared papers)Pui‐Kai Li (11 shared papers)Junyi Guo (12 shared papers)Zheng Y. X. Huang (1 shared paper)Fang Liu (1 shared paper)Dehan Liu (6 shared papers)
- Journals
- Oncotarget (4 papers)PLoS ONE (4 papers)European Journal of Pharmacology (4 papers)International Journal of Oncology (3 papers)Frontiers in Cardiovascular Medicine (3 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Li Lin
116 papers receiving 6.2k citations
Li Lin's Hit Papers
Peers
Comparison fields: 5 of 152
- Infectious Diseases 1.4k
- Oncology 1.5k
- Obstetrics and Gynecology 411
- Toxicology 159
- Neurology 638
Countries citing papers authored by Li Lin
This map shows the geographic impact of Li Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Lin more than expected).
Fields of papers citing papers by Li Lin
This network shows the impact of papers produced by Li Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Lin. The network helps show where Li Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19 Hit paper breakdown → | 2020 | 845 |
| 2 | 2020 | 398 | |
| 3 | 2020 | 384 | |
| 4 | 2020 | 284 | |
| 5 | 2011 | 265 | |
| 6 | 2010 | 217 | |
| 7 | 1990 | 203 | |
| 8 | 2009 | 182 | |
| 9 | 2010 | 178 | |
| 10 | 2020 | 169 | |
| 11 | 2020 | 146 | |
| 12 | 2014 | 139 | |
| 13 | 2010 | 137 | |
| 14 | Associations of Serum Folate and Vitamin B 12 Levels With Cardiovascular Disease Mortality Among Patients With Type 2 Diabetes Hit paper breakdown → | 2022 | 137 |
| 15 | 2014 | 135 | |
| 16 | 2011 | 105 | |
| 17 | 2023 | 104 | |
| 18 | 2020 | 99 | |
| 19 | 2009 | 85 | |
| 20 | 2010 | 84 |
About Li Lin
Li Lin is a scholar working on Oncology, Infectious Diseases, Molecular Biology, Immunology and Hematology, having authored 119 papers that have together received 6.4k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (19 papers), COVID-19 Clinical Research Studies (9 papers), Protein Tyrosine Phosphatases (6 papers), Cardiac electrophysiology and arrhythmias (5 papers), Hematopoietic Stem Cell Transplantation (5 papers), Ion channel regulation and function (4 papers), RNA modifications and cancer (4 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Infectious Diseases (1.4k citations), Oncology (1.5k citations), Obstetrics and Gynecology (411 citations), Toxicology (159 citations) and Neurology (638 citations). Li Lin has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Jiayuh Lin, Jiagao Lv, Chenglong Li, Pui‐Kai Li, Junyi Guo, Zheng Y. X. Huang, Fang Liu, Dehan Liu, Xiaoyang Song and Mengda Xu. Their work appears in journals such as Oncotarget, PLoS ONE, European Journal of Pharmacology, International Journal of Oncology and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.